2025

Gonadal hormones contribute to sex differences in behavior, pathology and epigenetic modifications in the 3×Tg-AD mouse model of Alzheimer’s disease

Authors:

Song, W., Creighton, S. D., Michalski, B., Mojgani, J., Kapadia, M., Ma, D., Sakic, B., Zovkic, I. B., & Fahnestock, M.

Journal:

Biology of Sex Differences

Abstract

Background: Sex-dependent differences in prevalence and severity are characteristics of Alzheimer’s disease (AD). Using the 3×Tg-AD mouse model, we previously reported that adult males show early behavioral dysfunction, altered epigenetic factors and lack of plaque/tangle pathology. Conversely, adult females retain more severe AD-like pathology and behavior. The present study examines whether gonadal hormones play a role in these differences in current cohorts of 3×Tg-AD mice.

Methods: 3×Tg-AD and wild-type mice were gonadectomized or sham-operated at 3 months of age. After behavioral phenotyping at 6 months of age, the animals were assessed for molecular markers of AD pathology and expression of genes and histone variants associated with neurodegeneration.

Results: In female transgenic (AD) mice, gonadectomy resulted in poorer spatial learning performance. In contrast, in transgenic male animals, gonadectomy improved spatial learning and memory. Compared to sham-operated AD females, gonadectomized AD females exhibited enhanced expression of mouse (m) Mapt and App genes, consistent with reduced binding activity of the repressive histone variant macroH2A1 at the mMapt gene, but there was no effect on Aβ42 or pTau181 levels. In contrast, gonadectomized AD males showed significantly increased macroH2A1 binding at the mPsen1 promoter, reduced expression of the App and MacroH2A1 genes, and reduced cortical soluble Aβ42 levels compared to sham-operated AD males.

Conclusions: In sum, the results suggest that reduction in serum levels of female gonadal hormones impairs spatial learning capacity, whereas loss of male gonadal hormones enhances spatial learning and memory. In females, gonadectomy reduces binding of the repressive histone variant MacroH2A1 to the mouse Mapt gene and increases expression of the mouse App and Mapt genes without affecting Aβ42 or pTau181 levels. Conversely, loss of male gonadal hormones increases binding of MacroH2A1 to the mouse Psen1 gene and decreases App expression and Aβ42 levels but has no effect on tau expression. Our work suggests that adult gonadal hormones contribute to sex differences in AD-like pathology and performance in learning and memory tasks. Moreover, sex-specific differences in AD-like pathology are partially due to the action of histone variants associated with neurodegeneration, such as macroH2A1.

Plain Language Summary

The question we studied: More women than men have Alzheimer’s disease, and it tends to be more severe in women – are sex hormones responsible?

How we studied it: We compared what happens to male and female mice when sex hormones are removed.

What we found: Removing sex hormones led to different results in male and female mice. Loss of sex hormones in males improved learning and memory and lowered amyloid-beta levels (a protein linked to Alzheimer’s disease). But in females, loss of sex hormones led to learning problems and did not affect amyloid-beta. These differences were linked to changes in how certain proteins attach to the DNA, which altered the amount of amyloid-beta differently in male versus female brains.

Why it matters: These results help us understand how Alzheimer’s disease works differently in males and females. This knowledge can be the basis for developing different treatments for males and females.

Share

CCNA - CCNV white logo

Receive the
latest news

Stay updated with the latest research developments from CCNA-CCNV. Our news section provides insights into cutting-edge studies, advancements in dementia care, and key findings in brain health research.

Illustration of elderly people on a park bench